Researchers investigate acceptability of potential HIV prevention device in Africa

November 11, 2008

(PhysOrg.com) -- For some women in the poorest parts of the Kenyan capital of Nairobi, being paid for sex is one of the few ways they are able to feed themselves and their children. In a region hit hard by the HIV/AIDS pandemic, they are at very high risk for contracting the disease.

Georgia State University researchers recently investigated whether these women, and their male clients, would accept a potential method of preventing HIV/AIDS which allows women to take control of their own health.

The device, an intravaginal ring containing chemicals microbicides, has the potential to let women reduce their risk of contracting the disease in an environment where many of their clients refuse to use condoms.

“This group of women are really stressed, and are often supporting children,” said Donna Smith, a research associate with the Georgia State Institute of Public Health. “These are not women who are making a decent living. They’re just getting by and just one client walking away could be the difference between eating or not.”

Working with colleagues such as Frances Priddy of Emory University, as well as Sabina Wakasiaka and the late Job Joab Bwayo of Kenya AIDS Vaccine Initiative, Smith and data coordinator Tina Hoang asked questions among female sex workers in the Nairobi slum community of Mukuru.

Scientists are working to develop microbicides which reduce the spread of HIV, and several types which could be used by women are in development. None have been found yet which have been proven effective in reducing the transmission of HIV/AIDS, but it is believed that an effective one will be developed in the future before a vaccine becomes available, Smith said.

An intravaginal ring, similar to the NuvaRing used currently for birth control in developed countries, could be used to release the microbicide, allowing women to potentially use the device without their partner becoming aware of it.

In the qualitative study published in the Journal of Women’s Health, some women reported that they were comfortable with the idea of using the ring without letting their partner know, however, some of the male clients insisted on knowing that it was being used — and that if they became aware of the device, they would not pay or would pay less.

Overall, though, those participating in the focus group research, sponsored by the CDC Foundation, were open to the use of the ring.

“This should be your secret,” one woman responded. “You don’t need to tell him. You would be protecting yourself from those who want to infect you.”

Smith and Hoang are also working on a six-month cohort study to track rates of STD infection among sex workers, which will help give future microbicide and vaccine researchers more knowledge about high-risk populations.

Provided by Georgia State University

Explore further: Women sue healthcare giant Bayer over contraceptive implants

Related Stories

Women sue healthcare giant Bayer over contraceptive implants

December 9, 2016
French lawyers for women who say a contraceptive implant sold by Bayer Healthcare had caused a string of medical complications launched a lawsuit against the multinational on Friday.

Boomers' embrace of devices gives rise to new med-tech age

September 23, 2013
Jay Alva's sneakers pounded the treadmill, set to the speed of a brisk walk. Sweat dripped off the 53-year-old as he hit a groove during a recent workout.

Self-injection of contraception is feasible, acceptable in Uganda

November 16, 2016
Self-injection of the contraceptive Sayana Press is both feasible and highly acceptable among women participating in the first such research study conducted in sub-Saharan Africa, according to results published online by ...

French police arrest boss of breast implant company

January 26, 2012
French police on Thursday arrested Jean-Claude Mas, the founder of the PIP breast implant company that sparked a global health scare by using substandard silicone, as part of a manslaughter probe.

The microbial superhero in your vagina

October 11, 2016
The aisle is marked with a little red sign that says "Feminine Treatments". Squeezed between the urinary incontinence pads and treatments for yeast infections, there is a wall of bottles and packages in every pastel shade ...

Study identifies ways to increase IUD use in developing countries

February 15, 2013
Boosting demand for intrauterine devices, commonly referred to as IUDs, and improving access to them can significantly increase their use in developing countries, where they have traditionally been an unpopular method of ...

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.